维普中文期刊产品整合服务
2篇 您的检索式:作者名="Mark Hallman"
    题名 作者 年代 出处 被引量
1Therapeutic management options for stage Ⅲ non-small cell lung cancer显示文摘Lung cancer is the leading cause of cancer death worldwide.Majority of newly diagnosed lung cancers are non-small cell lung cancer(NSCLC), of which up to half are considered locally advanced at the time of diagnosis.Patients with locally advanced stage Ⅲ NSCLC consists of a heterogeneous population, making management for these patients complex.Surgery has long been the preferred local treatment for patients with resectable disease.For select patients, multimodality therapy involving systemic and radiation therapies in addition to surgery improves treatment outcomes compared to surgery alone.For patients with unresectable disease, concurrent chemoradiation is the preferred treatment.More recently, research into different chemotherapy agents, targeted therapies, radiation fractionation schedules, intensity-modulated radiotherapy, and proton therapy have shown promise to improve treatment outcomes and quality of life.The array of treatment approaches for locally advanced NSCLC is large and constantly evolving.An updated review of past and current literature for the roles of surgery, chemotherapeutic agents, radiation therapy, and targeted therapy for stage Ⅲ NSCLC patients are presented.Stephanie M Yoon Talha Shaikh Mark Hallman 2017World Journal of Clinical Oncology2017,8,1:32
2Alcohol Intake and Risk of Coronary Heart Disease in Younger, Middle-Aged, and Older Adults显示文摘Ulla A. Hvidtfeldt Janne S. Tolstrup Marianne U. Jakobsen Berit L. Heitmann Morten Gr?nb?k Eilis O?Reilly Katarina B?lter Uri Goldbourt G?ran Hallmans Paul Knekt Simin Liu Mark Pereira Pirjo Pietinen Donna Spiegelman June Stevens Jarmo Virtamo Walter C. W 2010Circulation2010,,14:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费